| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/27/2011 | US8026244 Thioxanthine derivatives and their use as inhibitors of MPO |
| 09/27/2011 | US8026243 [4,5′]Bipyrimidinyl-6,4′-diamine derivatives as protein kinase inhibitors |
| 09/27/2011 | US8026241 Vanilloid receptor ligands and their use in treatments |
| 09/27/2011 | US8026240 Octahydro-pyrrolo[3,4-b]pyrrole N-oxides |
| 09/27/2011 | US8026239 Cell differentiation inducer |
| 09/27/2011 | US8026233 P38 inhibitors and methods of use thereof |
| 09/27/2011 | CA2658462C Substituted pyridone compounds and methods of use |
| 09/27/2011 | CA2615611C Indazole derivatives |
| 09/27/2011 | CA2511307C Viral polymerase inhibitors |
| 09/27/2011 | CA2503646C Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors |
| 09/27/2011 | CA2487542C Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
| 09/27/2011 | CA2467683C 5-phenylpyrimidines, agents comprising the same, method for production and use thereof |
| 09/27/2011 | CA2457410C Compounds effecting glucokinase |
| 09/27/2011 | CA2440630C Metalloproteinase inhibitors |
| 09/27/2011 | CA2258728C Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| 09/22/2011 | WO2011116161A2 Arylsulfonamide ccr3 antagonists |
| 09/22/2011 | WO2011115813A1 Lactam acetamides as calcium channel blockers |
| 09/22/2011 | WO2011115804A1 Sgc stimulators |
| 09/22/2011 | WO2011115725A2 Indazole compounds and their uses |
| 09/22/2011 | WO2011115183A1 Novel monocyclic pyrimidine derivative |
| 09/22/2011 | WO2011115065A1 Cyclopropanecarboxylic acid derivative |
| 09/22/2011 | WO2011115029A1 Plant disease control agent |
| 09/22/2011 | WO2011114337A1 Process for the preparation of highly pure crystalline imatinib base |
| 09/22/2011 | WO2011113988A1 New derivatives of propargylamine having neuroprotective capacity for the treatment of alzheimer's and parkinson's diseases |
| 09/22/2011 | WO2011113894A1 Pyridine and pyrazine derivative for the treatment of cf |
| 09/22/2011 | WO2011113512A1 Morpholinylquinazolines |
| 09/22/2011 | WO2011113309A1 Pyrimidine derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists |
| 09/22/2011 | WO2010093706A8 Chemically programmed vaccination |
| 09/22/2011 | US20110230524 Substituted 2-(5-hydroxy-2-methyl-1h-indole-3-yl)acetic acids and ethers thereof and the use of same to treat viral diseases |
| 09/22/2011 | US20110230523 Transcription factor modulating compounds and methods of use thereof |
| 09/22/2011 | US20110230521 Pyrazole Compounds As CCR1 Antagonists |
| 09/22/2011 | US20110230517 Calcium receptor modulating agents |
| 09/22/2011 | US20110230498 Biaryl carboxamides |
| 09/22/2011 | US20110230497 Biologically active amides |
| 09/22/2011 | US20110230495 1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds |
| 09/22/2011 | US20110230494 Heteroaryl compounds and uses thereof |
| 09/22/2011 | US20110230492 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 09/22/2011 | US20110230491 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 09/22/2011 | US20110230490 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 09/22/2011 | US20110230488 Hybrid-ionone and curcumin molecules as anticancer agents |
| 09/22/2011 | US20110230487 Arylsulfonamide ccr3 antagonists |
| 09/22/2011 | US20110230485 6-phenyl-pyrimidin-4-yl-(phenylamine or phenoxy) derivatives useful as modulators of nicotinic acetylcholine receptors |
| 09/22/2011 | US20110230483 Pyridine and Pyrazine derivative for the Treatment of CF |
| 09/22/2011 | US20110230481 Derivatives of tetrabromobenzimidazole, a process for the preparation thereof, a pharmaceutical composition comprising the same, a method of using the same, a method for modulating or regulating serine/threonine kinases, and serine/threonine kinases modulating agent |
| 09/22/2011 | US20110230476 Pi3 kinase inhibitors and uses thereof |
| 09/22/2011 | US20110230467 4,6-diaminonicotinamide compound |
| 09/22/2011 | US20110230465 Viral polymerase inhibitors |
| 09/22/2011 | US20110230461 2,3-dihydro-1h-inden-1-yl-2,7-diazaspiro[3.5] nonane derivatives |
| 09/22/2011 | US20110230459 Lactam acetamides as calcium channel blockers |
| 09/22/2011 | US20110230458 Phenyl-heteroaryl derivatives and methods of use thereof |
| 09/22/2011 | US20110230457 Substituted Isoquinolinones and Quinazolinones |
| 09/22/2011 | US20110230454 (aza)indole derivative and use thereof for medical purposes |
| 09/22/2011 | US20110230446 Cathepsin cysteine protease inhibitors |
| 09/22/2011 | US20110230445 Substituted Heteroaryls |
| 09/22/2011 | US20110230419 Iap binding compounds |
| 09/22/2011 | US20110230350 Aryl-and hetarylsulfonamides as active ingredients against abiotic plant stress |
| 09/22/2011 | US20110229870 Disintegration of cellular components in body fluids |
| 09/22/2011 | US20110229568 Michael systems as transglutaminase inhibitors |
| 09/22/2011 | US20110229410 Technetium-dipyridine complexes, and methods of use thereof |
| 09/22/2011 | US20110227057 Perylene compound and organic light emitting device using the compound |
| 09/22/2011 | CA2793523A1 Cyclopropanecarboxylic acid derivative |
| 09/22/2011 | CA2793392A1 Pyridine and pyrazine derivative for the treatment of cf |
| 09/22/2011 | CA2793391A1 Arylsulfonamide ccr3 antagonists |
| 09/22/2011 | CA2793299A1 Morpholinylquinazolines |
| 09/22/2011 | CA2792472A1 Process for the preparation of highly pure crystalline imatinib base |
| 09/22/2011 | CA2791683A1 Plant disease control agent |
| 09/22/2011 | CA2791613A1 Indazole compounds and their uses |
| 09/21/2011 | EP2367001A1 Biospecific binding reactants labeled with new luminescent lanthanide chelates and their use |
| 09/21/2011 | EP2366699A1 8-substituted isoquinoline derivative and use thereof |
| 09/21/2011 | EP2366691A1 The nitropyridinyl ethyleneimine compound, the pharmaceutical composition containing it, the preparation method and use thereof |
| 09/21/2011 | EP2365971A1 Benzimidazole derivates and their use for modulating the gabaa, receptor complex |
| 09/21/2011 | EP2365970A1 Pyridazinones and their use as btk inhibitors |
| 09/21/2011 | EP2365965A1 Process for manufacturing substituted 3-pyridylmethyl ammonium bromides |
| 09/21/2011 | EP2365752A1 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities |
| 09/21/2011 | EP2365749A1 Quinolone neuropeptide s receptor antagonists |
| 09/21/2011 | EP2212283B1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 09/21/2011 | EP2212282B1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 09/21/2011 | EP2155683B8 Pyridone derivatives as p38a mapk inhibitors |
| 09/21/2011 | EP2024354B1 1- [ (4- [benzoyl (methyl) amino]-3- (phenyl) butyl]azetidine derivatives for the treatment of gastrointestinal disorders 1 |
| 09/21/2011 | EP1988777B1 Pyrazoles for the treatment of obesity and other cns disorders |
| 09/21/2011 | EP1675835B1 Methods of preparation of dehydro-diketopiperazines in liquid phase or on solid supported phase |
| 09/21/2011 | EP1505963B9 Hepatitis c virus inhibitors |
| 09/21/2011 | CN1926134B 2-pyridinylethylcarboxamide derivatives and their use as fungicides |
| 09/21/2011 | CN102197033A Pyrrole compounds |
| 09/21/2011 | CN102197032A Heterocyclic PIM-kinase inhibitors |
| 09/21/2011 | CN102197031A Substituted 5-aminopyrazoles and use thereof |
| 09/21/2011 | CN102190651A Ionic liquid type antistatic light stabilizer, and preparation method thereof |
| 09/21/2011 | CN102190650A Method for preparing indoquinoline tartrate |
| 09/21/2011 | CN102190649A Method for preparing alpha-imatinib mesylate |
| 09/21/2011 | CN102190625A Stilbene tumor targeted medicine Combretastatin A4 analogs |
| 09/21/2011 | CN101343250B Thrombopoietin mimetics |
| 09/20/2011 | US8022223 2-aminopyridine analogs as glucokinase activators |
| 09/20/2011 | US8022221 Aurora kinase modulators and method of use |
| 09/20/2011 | US8022213 6'-Bromo-1-[(5-methoxy-3-methyl-1H-indol-2-yl)carbonyl]-1'H-spiro[piperidine-4,4'-quinolin]-2'(3'H)-one; vasopressin receptors antagonist; antidepressant, anxiolytic agent; inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder |
| 09/20/2011 | US8022210 3-Aminopyrazine-2-carbonylguanidine derivatives; (4-{4-[N'-(3,5-Diamino-6-chloropyrazine-2-carbonyl)guanidino]butyl}phenoxy)acetic acid 2-piperidin-1-yl-ethyl ester; hydration of mucous membranes; respiratory system and gastrointestinal disorders; skin, eye and vaginal dryness; hypotensive agents; asthma |
| 09/20/2011 | US8022208 Benzene derivative or salt thereof |
| 09/20/2011 | US8022205 Pyrimidine derivatives as PI3K inhibitor and use thereof |
| 09/20/2011 | US8022202 Dihydrodiazepines useful as inhibitors of protein kinases |
| 09/20/2011 | US8022096 Pyrrolidine derivatives |
| 09/20/2011 | US8022085 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof |